Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track
Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK
Free Medical Books

Diabetes
Subscription from Paris

Email: Password:
Request password

Your AMEDEO page is free of charge.

This policy was made possible thanks to a media sponsorship by Boehringer Ingelheim.

2017-04-24

To download data for further processing, check single articles, then select "Medline format" and "Text only".

Abstract format   Medline format Web site   Text only

  1. Coates VE, Horigan G, Davies M, Davies MT, et al.
    Exploring why young people with Type 1 diabetes decline structured education with a view to overcoming barriers.
    Diabet Med. 2017 Apr 21. doi: 10.1111/dme.13368.
    PubMed - Related Articles    Abstract available

  2. Morgan NG.
    Bringing the human pancreas into focus: new paradigms for the understanding of Type 1 diabetes.
    Diabet Med. 2017 Apr 20. doi: 10.1111/dme.13365.
    PubMed - Related Articles    Abstract available

  3. Sultan A, Perriard F, Macioce V, Mariano-Goulart D, et al.
    Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in Type 2 diabetes over a 10-year period: an observational study.
    Diabet Med. 2017 Apr 18. doi: 10.1111/dme.13364.
    PubMed - Related Articles    Abstract available

  4. Holt RIG.
    Diabetes technology.
    Diabet Med. 2017;34:603.
    PubMed - Related Articles

  5. Al-Jobori H, Daniele G, Cersosimo E, Triplitt C, et al.
    Empagliflozin and Kinetics of Renal Glucose Transport in Healthy and Type 2 Diabetic Individuals.
    Diabetes. 2017 Apr 20. pii: db170100. doi: 10.2337/db17-0100.
    PubMed - Related Articles    Abstract available

  6. Xu H, Ryan KA, Jaworek TJ, Southam L, et al.
    Familial Hypercholesterolemia and Type 2 Diabetes in the Old Order Amish.
    Diabetes. 2017 Apr 20. pii: db170173. doi: 10.2337/db17-0173.
    PubMed - Related Articles    Abstract available

  7. Lo CS, Shi Y, Chenier I, Ghosh A, et al.
    Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.
    Diabetes. 2017 Apr 19. pii: db161588. doi: 10.2337/db16-1588.
    PubMed - Related Articles    Abstract available

  8. Rooijackers HM, Wiegers EC, van der Graaf M, Thijssen DH, et al.
    A Single Bout of High-Intensity Interval Training Reduces Awareness of Subsequent Hypoglycemia in Patients with Type 1 Diabetes.
    Diabetes. 2017 Apr 18. pii: db161535. doi: 10.2337/db16-1535.
    PubMed - Related Articles    Abstract available

  9. Emdin CA, Klarin D, Natarajan P, Florez JC, et al.
    Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease.
    Diabetes. 2017 Apr 14. pii: db170149. doi: 10.2337/db17-0149.
    PubMed - Related Articles    Abstract available

  10. Aroda VR, Rosenstock J, Wysham C, Unger J, et al.
    Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972-1
    Diabetes Care. 2017 Apr 20. pii: dc17er06d. doi: 10.2337.
    PubMed - Related Articles

  11. O'Brien SH, Vesely SK, Schwarz EB.
    Response to Comment on O'Brien et al. Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes. Diabetes Care 2017;40:233-238.
    Diabetes Care. 2017;40:e62.
    PubMed - Related Articles

  12. Braillon A.
    Comment on O'Brien et al. Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes. Diabetes Care 2017;40:233-238.
    Diabetes Care. 2017;40:e61.
    PubMed - Related Articles

  13. Chen MH.
    Response to Comment on Chen et al. Risk of Developing Type 2 Diabetes in Adolescents and Young Adults With Autism Spectrum Disorder: A Nationwide Longitudinal Study. Diabetes Care 2016;39:788-793.
    Diabetes Care. 2017;40:e60.
    PubMed - Related Articles

  14. Li YJ, Li YM.
    Comment on Chen et al. Risk of Developing Type 2 Diabetes in Adolescents and Young Adults With Autism Spectrum Disorder: A Nationwide Longitudinal Study. Diabetes Care 2016;39:788-793.
    Diabetes Care. 2017;40:e59.
    PubMed - Related Articles

  15. Jackson J, Posgai A, Campbell-Thompson M, Kusmartseva I, et al.
    Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus.
    Diabetes Care. 2017;40:723-725.
    PubMed - Related Articles

  16. Pickup JC, Reznik Y, Sutton AJ.
    Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials.
    Diabetes Care. 2017;40:715-722.
    PubMed - Related Articles    Abstract available

  17. .
    In This Issue of Diabetes Care.
    Diabetes Care. 2017;40:627-628.
    PubMed - Related Articles

  18. Dubois-Laforgue D, Cornu E, Saint-Martin C, Coste J, et al.
    Diabetes, Associated Clinical Spectrum, Long-term Prognosis and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1 B (HNF1B) Molecular Defects.
    Diabetes Care. 2017 Apr 18. pii: dc162462. doi: 10.2337/dc16-2462.
    PubMed - Related Articles    Abstract available

  19. Mita T, Katakami N, Yoshii H, Onuma T, et al.
    Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:1
    Diabetes Care. 2017 Apr 18. pii: dc17er06b. doi: 10.2337.
    PubMed - Related Articles

  20. Kazda CM, Ding Y, Kelly RP, Garhyan P, et al.
    Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.
    Diabetes Care. 2017 Apr 18. pii: dc17er06. doi: 10.2337.
    PubMed - Related Articles

  21. Mita T, Katakami N, Shiraiwa T, Yoshii H, et al.
    Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes
    Diabetes Care. 2017 Apr 18. pii: dc17er06a. doi: 10.2337.
    PubMed - Related Articles

  22. Rosenstock J, Aronson R, Grunberger G, Hanefeld M, et al.
    Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial
    Diabetes Care. 2017 Apr 18. pii: dc17er06c. doi: 10.2337.
    PubMed - Related Articles

  23. Rajasekeran H, Kim SJ, Cardella CJ, Schiff J, et al.
    Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case Series.
    Diabetes Care. 2017 Apr 17. pii: dc170237. doi: 10.2337/dc17-0237.
    PubMed - Related Articles

  24. .
    Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    N Engl J Med. 2017;376:1507-1516.
    PubMed - Related Articles    Abstract available

  25. Rosenberg JB, Tsui I.
    Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;376:1587-1588.
    PubMed - Related Articles



Thank you for your interest in scientific medicine.


Design: